Showing articles whose micro-themes are very close to:
#drug reimbursement
- No closely related articles found yet.
- GLP-1 Receptor Agonists Show Potential Cancer Prevention Benefits in Preclinical and Observational Studies (sciencenews.org) | 15d ago
- NCPE Assessment: Belzutifan not cost-effective for VHL disease-associated tumours at current price (ncpe.ie) | 39d ago
- Reimbursement dispute over prostate cancer drug delays patient access (medicalindependent.ie) | 14d ago
- Seanad Éireann Debate on NCPE Cost-Benefit Analysis (oireachtas.ie) | 124d ago
- NCPE Publishes Updated Budget Impact Model Template v2.3 for Drug Reimbursement Submissions (ncpe.ie) | 57d ago
- NCPE Recommends Against Reimbursement of Belzutifan (Welireg) for von Hippel-Lindau Disease in Ireland (ncpe.ie) | 15d ago
- Cost-Effectiveness Evidence on Approved Cancer Drugs in Ireland (pmc.ncbi.nlm.nih.gov) | 17d ago
- Analysis of Ireland's Pharmaceutical Pricing and Reimbursement Framework and Hi-Tech Scheme (lexology.com) | 17d ago
- Oireachtas Debate on Medicinal Products Questions HSE Reimbursement (oireachtas.ie) | 98d ago
- IPHA-HSE Framework Agreement on Medicine Pricing 2026-2029 (ipha.ie) | 98d ago
Showing page 1 of 1
(10 total results)
← Prev
Next →